Back to RAYMOND JAMES FINANCIAL INC RAYMOND JAMES FINANCIAL INC

XLOXLO
6 quarters

Position history for RAYMOND JAMES FINANCIAL INCRAYMOND JAMES FINANCIAL INC's holdings in XILIO THERAPEUTICS INC

RAYMOND JAMES FINANCIAL INC previously held 0 shares of XLO (XILIO THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$47,832

Total Shares Change

-50,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$8.41
0
2025-Q4
Unchanged
18,761
0.0%
$12,0110.0%$8.96
0
2025-Q3
Unchanged
18,761
0.0%
$15,8100.0%$11.80
0
2025-Q2
Decreased
18,761
-44.8%
$12,7560.0%$9.52
0
2025-Q1
Decreased
33,961
-32.2%
$24,6010.0%$10.14
0
2024-Q4
New
50,086
-
$47,8320.0%$13.37
31

Other major holders of XLO: RA CAPITAL MANAGEMENT, L.P., NORGES BANK, FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used